Fred Hutchinson Cancer Center
Clinical trials sponsored by Fred Hutchinson Cancer Center, explained in plain language.
-
Can an antiviral drug help sepsis patients breathe easier?
Prevention TerminatedThis study tested whether the antiviral drug ganciclovir could prevent the reactivation of cytomegalovirus (CMV) in adults with sepsis and acute respiratory failure. The goal was to see if it would increase the number of days patients could breathe without a ventilator. The study…
Phase: PHASE3 • Sponsor: Fred Hutchinson Cancer Center • Aim: Prevention
Last updated May 01, 2026 16:01 UTC
-
New study aims to ease suffering after stem cell transplants in vulnerable patients
Symptom relief TerminatedThis study tested two approaches—supportive and palliative care (focusing on symptom relief) and clinical management of other health problems (like heart or lung disease)—to see if they could improve quality of life and survival after a donor stem cell transplant. It included 458…
Phase: PHASE2, PHASE3 • Sponsor: Fred Hutchinson Cancer Center • Aim: Symptom relief
Last updated Apr 30, 2026 15:52 UTC